(Date:11/5/2009).... 5 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
(Date:11/5/2009)...mber 5, 2009 Senomyx, In...oprietary taste receptor-based technologies to dis...age, and ingredient supply industries, today provi...lts for the third quarter ended September 30, 2009...r of 2009, compared to $4.0 million for the third ...
(Date:11/5/2009)...G, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP ...ne" or the "Company") today announced,that the Com... results on,Monday, November 9, 2009, after the ma...nference call at 5:00 pm ET on November 9, 2009,to...y access the call by,dialing 1-888-713-4211 or 1-6...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Repro , ...r 5, 2009 -- Professional Reprographics, Orange Co... is pleased to present Brooke Sanders to the compa...specialist. The addition of Brooke to the company ...Professional Reprographics., , ,Brooke brings with...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2...e in Adoption of Incisionless Natural Orifi...LEMENTE, Calif., Dec. 19 USGI Medical, Inc., the,...ry, today announced that,its EndoSurgical Operatin...to effectively close a gastrotomy (an incision in ...US. Leading surgeons demonstrated the gastrotomy,c...
...ive license,for the development and commercialisat...in Cystic Fibrosis patients was signed today. As p... Japan transferred relevant,rights to Axentis Phar...,orphan drug status to the licensed technology and...entis Pharma AG in early 2008., Axentis Pharma AG...
...ionise the transformation of solar energy to elect...t from solar electricity and save money in the fut... cells meet the expectations, both your economy an...Less than 1 per cent of the worlds electricity com...rm solar energy to electricity. But Martin Aagesen...
Other Biology Technology:USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES 2Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections 2Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections 3(Date:11/4/2009)...niversity of Oklahoma at Norman has received more ...ing agencies as part of the federal stimulus progr...eceived by OU researchers to $23 million. Thirty-...ch ranging from archaeology to weather. , "The u... approach to matching areasof scholarly excellence...
(Date:11/4/2009)...ADISON, N.J., Oct. 20 Qu...rld,s leading provider of diagnostic testing, info... quarter ended September 30, 2009, income from con...per diluted share, from $160 million, or $0.81 per...2008, third quarter results were reduced by a $0.0...
(Date:11/4/2009)...EDFORD, Mass., Oct. 20 A... broadband technology and biometrics software, tod...er ended September 30, 2009. ,, Michael Tzann...said, "Earlier today, we announced an agreement to... Lantiq, a new fabless semiconductor company being...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 1Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 2Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 3Helix BioPharma Corp Announces Fiscal 2009 Results 5849 1Helix BioPharma Corp Announces Fiscal 2009 Results 5849 2Helix BioPharma Corp Announces Fiscal 2009 Results 5849 3Helix BioPharma Corp Announces Fiscal 2009 Results 5849 4Helix BioPharma Corp Announces Fiscal 2009 Results 5849 5Helix BioPharma Corp Announces Fiscal 2009 Results 5849 6Helix BioPharma Corp Announces Fiscal 2009 Results 5849 7Helix BioPharma Corp Announces Fiscal 2009 Results 5849 8Helix BioPharma Corp Announces Fiscal 2009 Results 5849 9Helix BioPharma Corp Announces Fiscal 2009 Results 5849 10Helix BioPharma Corp Announces Fiscal 2009 Results 5849 11Helix BioPharma Corp Announces Fiscal 2009 Results 5849 12Helix BioPharma Corp Announces Fiscal 2009 Results 5849 13Detergent-OUT Micro Kit from CHEMICON
Polaroid Wide and Long Electrophoresis Hood from Bio-Rad
...microarrays are derived from Paraffin embedded tis...y control procedures to ensure the highest quality...one block, sectioned at a thickness of 5 microns a...-5 mm in diameter) in comparison to core sections ...
...microarrays are derived from frozen embedded tissu...control procedures to ensure the highest quality. ...e block, sectioned at a thickness of 7microns and ...m in diameter) in comparison to core sections made...
Biology Products: